Transient receptor potential ion channels: Powerful regulators of cell function

Annals of Surgery

Volumn 259, Issue 2, 2014, Pages 229-235

  Billeter, Adrian T ^a   Hellmann, Jason L ^a   Bhatnagar, Aruni ^a   Polk, Hiram C ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

inflammation; pain; TRP channels; TRPA1; TRPV1

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; VANILLOID RECEPTOR 6;

ANALGESIA; APOPTOSIS; CELL ACTIVATION; CELL FUNCTION; CHRONIC PAIN; DISEASE PREDISPOSITION; ELECTIVE SURGERY; HUMAN; HYPERTHERMIA; HYPOTHERMIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; INJURY; MACROPHAGE FUNCTION; MELANOMA; NEUROPATHIC PAIN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SURGICAL PATIENT;

EID: 84892948595     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182a6359c     Document Type: Review

References (86)

1. Inaba K, Teixeira PG, Rhee P, et al. Mortality impact of hypothermia after cavitary explorations in trauma. World J Surg. 2009;33:864-869.
2. Palm K, Apodaca A, Spencer D, et al. Evaluation of military trauma system practices related to damage-control resuscitation. J Trauma Acute Care Surg. 2012;73(suppl 5):S459-S464.
3. KlugerMJ. Fever, Its Biology, Evolution, and Function. Princeton, NJ: Princeton University Press; 1979.
4. Lairet JR, Bebarta VS, Burns CJ, et al. Prehospital interventions performed in a combat zone: a prospective multicenter study of 1,003 combat wounded. J Trauma Acute Care Surg. 2012;73(suppl 1):S38-S42.
5. Voets T, Talavera K, Owsianik G, et al. Sensing with TRP channels. Nat Chem Biol. 2005;1:85-92.
6. Clapham DE, Runnels LW, Strubing C. The TRP ion channel family. Nat Rev Neurosci. 2001;2:387-396.
7. Nilius B, Owsianik G, Voets T, et al. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165-217.
8. Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011;12:218.
9. Cosens DJ, Manning A. Abnormal electroretinogram from a Drosophila mutant. Nature. 1969;224:285-287.
10. Montell C, Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron. 1989;2:1313-1323.
11. Kilfoil PJ, Tipparaju SM, Barski OA, et al. Regulation of ion channels by pyridine nucleotides. Circ Res. 2013;112:721-741.
12. Deeds J, Cronin F, Duncan LM. Patterns of melastatin mRNA expression in melanocytic tumors. Hum Pathol. 2000;31:1346-1356.
13. Duncan LM, Deeds J, Cronin FE, et al. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol. 2001;19:568-576.
14. Wilson PD. Polycystic kidney disease. N Engl J Med. 2004;350:151-164.
15. Mene P, Punzo G, Pirozzi N. TRP channels as therapeutic targets in kidney disease and hypertension. Curr Top Med Chem. 2013;13:386-397.
16. Ishii S, Kurokawa A, Kishi M, et al. The response of PKD1L3/PKD2L1 to acid stimuli is inhibited by capsaicin and its pungent analogs. FEBS J. 2012;279:1857-1870.
17. Aguiari G, Catizone L, Del Senno L. Multidrug therapy for polycystic kidney disease: a review and perspective. Am J Nephrol. 2013;37:175-182.
18. Yu Y, Ulbrich MH, Li MH, et al. Molecular mechanism of the assembly of an acid-sensing receptor ion channel complex. Nat Commun. 2012;3:1252.
19. Feng S, Rodat-Despoix L, Delmas P, et al. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel. J Biol Chem. 2011;286: 18994-19000.
20. Trevisan G, Materazzi S, Fusi C, et al. Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade. Cancer Res. 2013;73:3120-3131.
21. Szallasi A, ShetaM. Targeting TRPV1 for pain relief: limits, losers and laurels. Expert Opin Investig Drugs. 2012;21:1351-1369.
22. Kissin I, Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem. 2011;11:2159-2170.
23. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-Activated ion channel in the pain pathway. Nature. 1997;389:816-824.
24. Cesare P, McNaughton P. A novel heat-Activated current in nociceptive neurons and its sensitization by bradykinin. Proc Natl Acad Sci USA. 1996;93: 15435-15439.
25. Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306-313.
26. Davis JB, Gray J, Gunthorpe MJ, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 2000;405:183-187.
27. Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci. 2002;5: 546-551.
28. Vay L, Gu C,McNaughton PA. The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol. 2012;165:787-801.
29. Mandadi S, Armati PJ, Roufogalis BD. Protein kinase Cmodulation of thermosensitive transient receptor potential channels: implications for pain signaling. J Nat Sci Biol Med. 2011;2:13-25.
30. Bautista DM, PellegrinoM, TsunozakiM. TRPA1: a gatekeeper for inflammation. Annu Rev Physiol. 2013;75:181-200.
31. Holzer P. Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther. 2011;131:142-170.
32. Chen J, Joshi SK, DiDomenico S, et al. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain. 2011;152:1165-1172.
33. Nassini R, Gees M, Harrison S, et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 2011;152: 1621-1631.
34. Bonet IJ, Fischer L, Parada CA, et al. The role of transient receptor potential A 1 (TRPA1) in the development and maintenance of carrageenan-induced hyperalgesia. Neuropharmacology. 2013;65:206-212.
35. Zhao M, Isami K, Nakamura S, et al. Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain. 2012;8:55.
36. Brierley SM, Castro J,Harrington AM, et al. TRPA1 contributes to specific mechanically activated currents and sensory neuron mechanical hypersensitivity. J Physiol. 2011;589:3575-3593.
37. Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010;66:671-680.
38. Obata K, Katsura H, Mizushima T, et al. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest. 2005;115:2393-2401.
39. Katsura H, Obata K, Mizushima T, et al. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp Neurol. 2006;200:112-123.
40. Engel MA, Leffler A, Niedermirtl F, et al. TRPA1 and substance P mediate colitis in mice. Gastroenterology. 2011;141:1346-1358.
41. Hatano N, Itoh Y, Suzuki H, et al. Hypoxia-inducible factor-1alpha (HIF1alpha) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like motif to modulate cytokine release. J Biol Chem. 2012;287:31962-31972.
42. Amadesi S, Nie J, Vergnolle N, et al. Protease-Activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci. 2004;24:4300-4312.
43. Staruschenko A, Jeske NA, Akopian AN. Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel. J Biol Chem. 2010;285:15167-15177.
44. Salas MM, Hargreaves KM, Akopian AN. TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1. Eur J Neurosci. 2009;29:1568-1578.
45. Engler A, Aeschlimann A, Simmen BR, et al. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun. 2007;359:884-888.
46. Okada Y, Reinach PS, Shirai K, et al. TRPV1 involvement in inflammatory tissue fibrosis in mice. Am J Pathol. 2011;178:2654-2664.
47. Sadofsky LR, Ramachandran R, Crow C, et al. Inflammatory stimuli upregulate transient receptor potential vanilloid-1 expression in human bronchial fibroblasts. Exp Lung Res. 2012;38:75-81.
48. Nassini R, Materazzi S, Andre E, et al. Acetaminophen, via its reactive metabolite N-Acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J. 2010;24:4904-4916.
49. Trevisani M, Siemens J, Materazzi S, et al. 4-hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA. 2007;104: 13519-13524.
50. van der Gaag NA, van Gulik TM, Busch OR, et al. Functional and medical outcomes after tailored surgery for pain due to chronic pancreatitis. Ann Surg. 2012;255:763-770.
51. Borsook D, Kussman BD, George E, et al. Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg. 2013;257:403-412.
52. Novakova-Tousova K, Vyklicky L, Susankova K, et al. Functional changes in the vanilloid receptor subtype 1 channel during and after acute desensitization. Neuroscience. 2007;149:144-154.
53. Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci. 2007;27:3366-3374.
54. Honore P, Chandran P, Hernandez G, et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain. 2009;142:27-35.
55. Steiner AA, Turek VF, Almeida MC, et al. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci. 2007;27:7459-7468.
56. Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309: 1359-1367.
57. Spite M, Summers L, Porter TF, et al. Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br J Pharmacol. 2009;158:1062-1073.
58. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361.
59. Park CK, Xu ZZ, Liu T, et al. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J Neurosci. 2011;31:18433-18438.
60. Park CK, Lu N, Xu ZZ, et al. Resolving TRPV1-And TNF-Alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci. 2011;31:15072-15085.
61. Knowles H, Heizer JW, Li Y, et al. Transient receptor potential melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes. Proc Natl Acad Sci USA. 2011;108:11578-11583.
62. Knowles H, Li Y, Perraud AL. The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation. Immunol Res. 2013;55:241-248.
63. Yamamoto S, Shimizu S, Kiyonaka S, et al. TRPM2-mediated Ca2+ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008;14:738-747.
64. Serafini N, Dahdah A, Barbet G, et al. The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsis. J Immunol. 2012;189:3689-3699.
65. Fernandes ES, Liang L, Smillie SJ, et al. TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome. J Immunol. 2012;188:5741-5751.
66. Clark N, Keeble J, Fernandes ES, et al. The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J. 2007;21:3747-3755.
67. Polk HC Jr, George CD, Wellhausen SR, et al. A systematic study of host defense processes in badly injured patients. Ann Surg. 1986;204:282-299.
68. Wehrhahn J, Kraft R, Harteneck C, et al. Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes. J Immunol. 2010;184:2386-2393.
69. Kashio M, Sokabe T, Shintaku K, et al. Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions. Proc Natl Acad Sci USA. 2012;109:6745-6750.
70. Wang S, Lee J, Ro JY, et al. Warmth suppresses and desensitizes damagesensing ion channel TRPA1. Mol Pain. 2012;8:22.
71. Demirbilek S, Ersoy MO, Karaman A, et al. Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg. 2004;99:1501-1507; table of contents.
72. Clapham DE. Calcium signaling. Cell. 2007;131:1047-1058.
73. Bukur M, Hadjibashi AA, Ley EJ, et al. Impact of prehospital hypothermia on transfusion requirements and outcomes. J Trauma Acute Care Surg. 2012;73:1195-1201.
74. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl JMed. 1996;334:1209-1215.
75. Laupland KB, Zahar JR, Adrie C, et al. Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med. 2012;40: 145-151.
76. Belvisi MG, Dubuis E, Birrell MA. Transient receptor potential A1 channels: insights into cough and airway inflammatory disease. Chest. 2011;140: 1040-1047.
77. BessacBF, Jordt SE. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda). 2008;23:360-370.
78. Geppetti P, Patacchini R, Nassini R, et al. Cough: the emerging role of the TRPA1 channel. Lung. 2010;188(suppl 1):S63-S68.
79. Nassini R, Pedretti P, Moretto N, et al. Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation. PLoS One. 2012;7:e42454.
80. Caceres AI, Brackmann M, Elia MD, et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci USA. 2009;106:9099-9104.
81. Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. Biochim Biophys Acta. 2007;1772:937-946.
82. Devi S, Kedlaya R, Maddodi N, et al. Calcium homeostasis in human melanocytes: role of transient receptor potential melastatin 1 (TRPM1) and its regulation by ultraviolet light. Am J Physiol Cell Physiol. 2009;297: C679-C687.
83. Mazar J, DeYoung K, Khaitan D, et al. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One. 2010;5: e13779.
84. Lehen'kyi V, Raphael M, Prevarskaya N. The role of the TRPV6 channel in cancer. J Physiol. 2012;590:1369-1376.
85. Thebault S, Roudbaraki M, Sydorenko V, et al. Alpha1-Adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells. J Clin Invest. 2003;111:1691-1701.
86. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11-21.